BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 27280335)

  • 1. Hydrogen Sulfide Triggered Charge-Reversal Micelles for Cancer-Targeted Drug Delivery and Imaging.
    Zhang H; Kong X; Tang Y; Lin W
    ACS Appl Mater Interfaces; 2016 Jun; 8(25):16227-39. PubMed ID: 27280335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PEG-b-PCL copolymer micelles with the ability of pH-controlled negative-to-positive charge reversal for intracellular delivery of doxorubicin.
    Deng H; Liu J; Zhao X; Zhang Y; Liu J; Xu S; Deng L; Dong A; Zhang J
    Biomacromolecules; 2014 Nov; 15(11):4281-92. PubMed ID: 25325531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. pH-Triggered Charge-Reversal Polyurethane Micelles for Controlled Release of Doxorubicin.
    He W; Zheng X; Zhao Q; Duan L; Lv Q; Gao GH; Yu S
    Macromol Biosci; 2016 Jun; 16(6):925-35. PubMed ID: 26841363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exogenous Vitamin C-Triggered Surface Charge Conversion of pH/Reduction-Responsive Micelles for the Enhanced Tumor-Specific Activity of Loaded Doxorubicin.
    Wu Z; Chen B; Gan Z; Chen F; Luo X
    Mol Pharm; 2020 Mar; 17(3):954-964. PubMed ID: 31977226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polypeptide-based "smart" micelles for dual-drug delivery: a combination study of experiments and simulations.
    Chen L; Jiang T; Cai C; Wang L; Lin J; Cao X
    Adv Healthc Mater; 2014 Sep; 3(9):1508-17. PubMed ID: 24652770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Facile preparation of core cross-linked nanomicelles based on graft copolymers with pH responsivity and reduction sensitivity for doxorubicin delivery.
    Chen T; Xiao Y; Lu W; Liu S; Gan L; Yu J; Huang J
    Colloids Surf B Biointerfaces; 2018 Jan; 161():606-613. PubMed ID: 29156337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Micelles of d-α-Tocopheryl Polyethylene Glycol 2000 Succinate (TPGS 2K) for Doxorubicin Delivery with Reversal of Multidrug Resistance.
    Hao T; Chen D; Liu K; Qi Y; Tian Y; Sun P; Liu Y; Li Z
    ACS Appl Mater Interfaces; 2015 Aug; 7(32):18064-75. PubMed ID: 26214761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction-responsive disassemblable core-cross-linked micelles based on poly(ethylene glycol)-b-poly(N-2-hydroxypropyl methacrylamide)-lipoic acid conjugates for triggered intracellular anticancer drug release.
    Wei R; Cheng L; Zheng M; Cheng R; Meng F; Deng C; Zhong Z
    Biomacromolecules; 2012 Aug; 13(8):2429-38. PubMed ID: 22746534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. pH-sensitive doxorubicin-conjugated prodrug micelles with charge-conversion for cancer therapy.
    Ma B; Zhuang W; Wang Y; Luo R; Wang Y
    Acta Biomater; 2018 Apr; 70():186-196. PubMed ID: 29452272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smart pH-sensitive micelles based on redox degradable polymers as DOX/GNPs carriers for controlled drug release and CT imaging.
    Xiong D; Zhang X; Peng S; Gu H; Zhang L
    Colloids Surf B Biointerfaces; 2018 Mar; 163():29-40. PubMed ID: 29278801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amphiphilic multi-arm-block copolymer conjugated with doxorubicin via pH-sensitive hydrazone bond for tumor-targeted drug delivery.
    Prabaharan M; Grailer JJ; Pilla S; Steeber DA; Gong S
    Biomaterials; 2009 Oct; 30(29):5757-66. PubMed ID: 19643472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Doxorubicin-Loaded Unimolecular Micelle-Stabilized Gold Nanoparticles as a Theranostic Nanoplatform for Tumor-Targeted Chemotherapy and Computed Tomography Imaging.
    Lin W; Zhang X; Qian L; Yao N; Pan Y; Zhang L
    Biomacromolecules; 2017 Dec; 18(12):3869-3880. PubMed ID: 29032674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fine tuning micellar core-forming block of poly(ethylene glycol)-block-poly(ε-caprolactone) amphiphilic copolymers based on chemical modification for the solubilization and delivery of doxorubicin.
    Yan J; Ye Z; Chen M; Liu Z; Xiao Y; Zhang Y; Zhou Y; Tan W; Lang M
    Biomacromolecules; 2011 Jul; 12(7):2562-72. PubMed ID: 21598958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stepwise pH/reduction-responsive polymeric conjugates for enhanced drug delivery to tumor.
    Yang S; Wang Y; Ren Z; Chen M; Chen W; Zhang X
    Mater Sci Eng C Mater Biol Appl; 2018 Jan; 82():234-243. PubMed ID: 29025653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxime linkage: a robust tool for the design of pH-sensitive polymeric drug carriers.
    Jin Y; Song L; Su Y; Zhu L; Pang Y; Qiu F; Tong G; Yan D; Zhu B; Zhu X
    Biomacromolecules; 2011 Oct; 12(10):3460-8. PubMed ID: 21863891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted doxorubicin nanotherapy strongly suppressing growth of multidrug resistant tumor in mice.
    Nguyen DH; Lee JS; Bae JW; Choi JH; Lee Y; Son JY; Park KD
    Int J Pharm; 2015 Nov; 495(1):329-335. PubMed ID: 26325307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual pH-responsive-charge-reversal micelle platform for enhanced anticancer therapy.
    Liao J; Peng H; Liu C; Li D; Yin Y; Lu B; Zheng H; Wang Q
    Mater Sci Eng C Mater Biol Appl; 2021 Jan; 118():111527. PubMed ID: 33255080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amphiphilic Diblock Terpolymer PMAgala-b-P(MAA-co-MAChol)s with Attached Galactose and Cholesterol Grafts and Their Intracellular pH-Responsive Doxorubicin Delivery.
    Wang Z; Luo T; Sheng R; Li H; Sun J; Cao A
    Biomacromolecules; 2016 Jan; 17(1):98-110. PubMed ID: 26682643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanomicelles based on a boronate ester-linked diblock copolymer as the carrier of doxorubicin with enhanced cellular uptake.
    Xu Y; Lu Y; Wang L; Lu W; Huang J; Muir B; Yu J
    Colloids Surf B Biointerfaces; 2016 May; 141():318-326. PubMed ID: 26874117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Redox and pH-responsive degradable micelles for dually activated intracellular anticancer drug release.
    Chen W; Zhong P; Meng F; Cheng R; Deng C; Feijen J; Zhong Z
    J Control Release; 2013 Aug; 169(3):171-9. PubMed ID: 23306022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.